Javascript must be enabled to continue!
Dissociative Model in Patients With Resistant Schizophrenia
View through CrossRef
BackgroundSchizophrenia is a severe mental illness in which, despite the growing number of antipsychotics from 30 to 50% of patients remain resistant to treatment. Many resistance factors have been identified. Dissociation as a clinical phenomenon is associated with a loss of integrity between memories and perceptions of reality. Dissociative symptoms have also been found in patients with schizophrenia of varying severity. The established dispersion of the degree of dissociation in patients with schizophrenia gave us reason to look for the connection between the degree of dissociation and resistance to therapy.MethodsThe type of study is correlation analysis. 106 patients with schizophrenia were evaluated. Of these, 45 with resistant schizophrenia and 60 with clinical remission. The Positive and Negative Syndrome Scale (PANSS) and Brief Psychiatric Rating Scale (BPRS) scales were used to assess clinical symptoms. The assessment of dissociative symptoms was made with the scale for dissociative experiences (DES). Statistical methods were used to analyze the differences in results between the two groups of patients.ResultsPatients with resistant schizophrenia have a higher level of dissociation than patients in remission. This difference is significant and demonstrative with more than twice the level of dissociation in patients with resistant schizophrenia.The level of dissociation measured in patients with resistant schizophrenia is as high as the points on the DES in dissociative personality disorder.ConclusionPatients with resistant schizophrenia have a much higher level of dissociation than patients in clinical remission. The established difference between the two groups support to assume that resistance to the administered antipsychotics is associated with the presence of high dissociation in the group of resistant patients. These results give us explanation to think about therapeutic options outside the field of antipsychotic drugs as well as to consider different strategies earlier in the diagnostic process.
Title: Dissociative Model in Patients With Resistant Schizophrenia
Description:
BackgroundSchizophrenia is a severe mental illness in which, despite the growing number of antipsychotics from 30 to 50% of patients remain resistant to treatment.
Many resistance factors have been identified.
Dissociation as a clinical phenomenon is associated with a loss of integrity between memories and perceptions of reality.
Dissociative symptoms have also been found in patients with schizophrenia of varying severity.
The established dispersion of the degree of dissociation in patients with schizophrenia gave us reason to look for the connection between the degree of dissociation and resistance to therapy.
MethodsThe type of study is correlation analysis.
106 patients with schizophrenia were evaluated.
Of these, 45 with resistant schizophrenia and 60 with clinical remission.
The Positive and Negative Syndrome Scale (PANSS) and Brief Psychiatric Rating Scale (BPRS) scales were used to assess clinical symptoms.
The assessment of dissociative symptoms was made with the scale for dissociative experiences (DES).
Statistical methods were used to analyze the differences in results between the two groups of patients.
ResultsPatients with resistant schizophrenia have a higher level of dissociation than patients in remission.
This difference is significant and demonstrative with more than twice the level of dissociation in patients with resistant schizophrenia.
The level of dissociation measured in patients with resistant schizophrenia is as high as the points on the DES in dissociative personality disorder.
ConclusionPatients with resistant schizophrenia have a much higher level of dissociation than patients in clinical remission.
The established difference between the two groups support to assume that resistance to the administered antipsychotics is associated with the presence of high dissociation in the group of resistant patients.
These results give us explanation to think about therapeutic options outside the field of antipsychotic drugs as well as to consider different strategies earlier in the diagnostic process.
Related Results
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
Abstract
Background
Evidence shows that schizophrenia is associated with increased incidence of cardiovascular diseases (CVD), i...
Suicide attempt during a dissociative fugue: additional challenges in assessing self-harm risk
Suicide attempt during a dissociative fugue: additional challenges in assessing self-harm risk
IntroductionSuicide attempts during dissociative fugue states pose distinct challenges in assessing self-harm risk. Dissociative fugue is characterized by sudden, unplanned travel ...
M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
Abstract
Background
This study aims to investigate the perception of schizophrenia, knowledge level about schizophrenia, stigma,...
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract
Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
Exploring sexual and romantic functioning as early risk factors of schizophrenia: a narrative review
Exploring sexual and romantic functioning as early risk factors of schizophrenia: a narrative review
Abstract
Background
Patients with schizophrenia frequently encounter challenges related to sexuality and intimacy; however, the ...
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
Abstract
Background
The role of oral and gut microbiomes in the pathogenesis of schizophrenia has recently come to light with th...
What is Schizophrenia?
What is Schizophrenia?
Many who pick up this book will be learning about schizophrenia for the first time, either because someone they care about has recently been diagnosed, or purely out of academic in...
Stigma Masyarakat Terhadap Penderita Skizofrenia
Stigma Masyarakat Terhadap Penderita Skizofrenia
Society's stigma against schizophrenia sufferers is a negative and discriminatory behavior towards individuals who suffer from schizophrenia. This stigma develops because of stereo...

